-
1
-
-
34247238869
-
Kidney and pancreas transplantation in the United States, 1996Y2005
-
Andreoni KA, Brayman KL, Guidinger MK, et al. Kidney and pancreas transplantation in the United States, 1996Y2005. Am J Transplant 2007; 7: 1359.
-
(2007)
Am J Transplant
, vol.7
, pp. 1359
-
-
Andreoni, K.A.1
Brayman, K.L.2
Guidinger, M.K.3
-
2
-
-
10844292763
-
Immunosuppressive drugs for kidney transplantation
-
Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715.
-
(2004)
N Engl J Med
, vol.351
, pp. 2715
-
-
Halloran, P.F.1
-
3
-
-
0024419167
-
FK 506 for liver, kidney, and pancreas transplantation
-
Starzl TE, Todo S, Fung J, et al. FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989; 2: 1000.
-
(1989)
Lancet
, vol.2
, pp. 1000
-
-
Starzl, T.E.1
Todo, S.2
Fung, J.3
-
4
-
-
26644469263
-
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data
-
Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 2005; 331: 810.
-
(2005)
BMJ
, vol.331
, pp. 810
-
-
Webster, A.C.1
Woodroffe, R.C.2
Taylor, R.S.3
-
5
-
-
0037006627
-
Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study
-
Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359: 741.
-
(2002)
Lancet
, vol.359
, pp. 741
-
-
Margreiter, R.1
-
6
-
-
0035081018
-
A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation
-
Sperschneider H. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. Transplant Proc 2001; 33: 1279.
-
(2001)
Transplant Proc
, vol.33
, pp. 1279
-
-
Sperschneider, H.1
-
7
-
-
37349034394
-
Reduced exposure to calcineurin inhibitors in renal transplantation
-
Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
-
(2007)
N Engl J Med
, vol.357
, pp. 2562
-
-
Ekberg, H.1
Tedesco-Silva, H.2
Demirbas, A.3
-
8
-
-
0025168461
-
The effect of prescribed daily dose frequency on patient medication compliance
-
Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881.
-
(1990)
Arch Intern Med
, vol.150
, pp. 1881
-
-
Eisen, S.A.1
Miller, D.K.2
Woodward, R.S.3
-
9
-
-
1642327515
-
Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review
-
Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769.
-
(2004)
Transplantation
, vol.77
, pp. 769
-
-
Butler, J.A.1
Roderick, P.2
Mullee, M.3
-
10
-
-
78649896434
-
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study
-
Kramer BK, Charpentier B, Backman L, et al. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant 2010; 10: 2632.
-
(2010)
Am J Transplant
, vol.10
, pp. 2632
-
-
Kramer, B.K.1
Charpentier, B.2
Backman, L.3
-
11
-
-
70350125161
-
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial
-
Wlodarczyk Z, Squifflet JP, Ostrowski M, et al. Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. Am J Transplant 2009; 9: 2505.
-
(2009)
Am J Transplant
, vol.9
, pp. 2505
-
-
Wlodarczyk, Z.1
Squifflet, J.P.2
Ostrowski, M.3
-
12
-
-
57349120571
-
Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats
-
Mitamura T, Yamada A, Hanaoka K, et al. Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats. J Toxicol Sci 2008; 33: 575.
-
(2008)
J Toxicol Sci
, vol.33
, pp. 575
-
-
Mitamura, T.1
Yamada, A.2
Hanaoka, K.3
-
13
-
-
33847758317
-
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/ MMF in de novo kidney transplant recipients
-
Silva HT Jr, Yang HC, Abouljoud M, et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/ MMF in de novo kidney transplant recipients. Am J Transplant 2007; 7: 595.
-
(2007)
Am J Transplant
, vol.7
, pp. 595
-
-
Silva Jr., H.T.1
Yang, H.C.2
Abouljoud, M.3
-
14
-
-
77957205275
-
Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation
-
Trunecka P, Boillot O, Seehofer D, et al. Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. Am J Transplant 2010; 10: 2313.
-
(2010)
Am J Transplant
, vol.10
, pp. 2313
-
-
Trunecka, P.1
Boillot, O.2
Seehofer, D.3
-
15
-
-
0033609074
-
Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: Results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8)
-
Grant D, Kneteman N, Tchervenkov J, et al. Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8). Transplantation 1999; 67: 1133.
-
(1999)
Transplantation
, vol.67
, pp. 1133
-
-
Grant, D.1
Kneteman, N.2
Tchervenkov, J.3
-
16
-
-
84862806052
-
Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial
-
Wlodarczyk Z, Ostrowski M, Mourad M, et al. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial. Ther Drug Monit 2012; 34: 143.
-
(2012)
Ther Drug Monit
, vol.34
, pp. 143
-
-
Wlodarczyk, Z.1
Ostrowski, M.2
Mourad, M.3
-
17
-
-
0032855982
-
Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients
-
Bottiger Y, Brattstrom C, Tyden G, et al. Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients. Br J Clin Pharmacol 1999; 48: 445.
-
(1999)
Br J Clin Pharmacol
, vol.48
, pp. 445
-
-
Bottiger, Y.1
Brattstrom, C.2
Tyden, G.3
-
19
-
-
0035080534
-
Experimental study of tacrolimus immunosuppression on the mode of administration: Efficacy of constant intravenous infusion avoiding C(max)
-
Ishibashi M, Yoshida K, Ozono S, et al. Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max). Transplant Proc 2001; 33: 559.
-
(2001)
Transplant Proc
, vol.33
, pp. 559
-
-
Ishibashi, M.1
Yoshida, K.2
Ozono, S.3
-
20
-
-
77952594383
-
Once daily tacrolimus formulation: Monitoring of plasma levels, graft function, and cardiovascular risk factors
-
Mecule A, Poli L, Nofroni I, et al. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. Transplant Proc 2010; 42: 1317.
-
(2010)
Transplant Proc
, vol.42
, pp. 1317
-
-
Mecule, A.1
Poli, L.2
Nofroni, I.3
-
21
-
-
84872956718
-
Improved adherence to tacrolimus once-daily formulation in renal recipients: A randomized controlled trial using electronicmonitoring
-
Kuypers DR, Peeters PC, Sennesael JJ, et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronicmonitoring. Transplantation 2013; 95: 333.
-
(2013)
Transplantation
, vol.95
, pp. 333
-
-
Kuypers, D.R.1
Peeters, P.C.2
Sennesael, J.J.3
-
22
-
-
0036842816
-
Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients
-
Hesse CJ, Baan CC, Balk AH, et al. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients. Transplant Proc 2002; 34: 2988.
-
(2002)
Transplant Proc
, vol.34
, pp. 2988
-
-
Hesse, C.J.1
Baan, C.C.2
Balk, A.H.3
-
23
-
-
6344257079
-
The EMIT 2000 tacrolimus assay: An application protocol for the Beckman Synchron LX20 PRO analyzer
-
LeGatt DF, Shalapay CE, Cheng SB. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer. Clin Biochem 2004; 37: 1022
-
(2004)
Clin Biochem
, vol.37
, pp. 1022
-
-
Legatt, D.F.1
Shalapay, C.E.2
Cheng, S.B.3
-
24
-
-
77955588938
-
Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients
-
Bazin C, Guinedor A, Barau C, et al. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients. J Pharm Biomed Anal 2010; 53: 997. Sciences
-
(2010)
J Pharm Biomed Anal
, vol.53
, pp. 997
-
-
Bazin, C.1
Guinedor, A.2
Barau, C.3
|